Wikimedia Commons. The Epstein-Barr virus (EBV) is so common that most people pick it up at some point, often as “mono,” and then forget abo ...
Discovered in 1964 by Anthony Epstein, Yvonne Barr, and Bert Achong, the Epstein-Barr virus (EBV) has intrigued tumor virologists due to its unique behavior. Typically, EBV establishes a lifelong, ...
Dr. Todd Maderis, ND Exploring immune dysregulation, viral reactivation, mitochondrial impairment, and treatment implications in post-EBV fatigue syndromes ...
Evidence is mounting that multiple sclerosis (MS) may be triggered by one of the most common viruses in the world. The ...
Resolution of Chronic Fatigue in a Patient With Post-COVID EBV Reactivation and Mold-Related Illness
Dr. Kasey Holland Hamski, ND A case illustrating the interplay between EBV reactivation, environmental mold exposure, and immune dysregulation in a patient ...
SEATTLE – February 17, 2026 – Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein-Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is ...
Nearly 95% of the global population is infected with Epstein-Barr virus, with some populations at higher risk for serious complications if the virus becomes activated.
Researchers are progressing towards a vaccine against Epstein-Barr virus (EBV), which affects 95% of the global population ...
Researchers may be closer to developing a vaccine that protects against Epstein-Barr, a common virus linked with infectious ...
Khaberni - Scientists at the Fred Hutch Cancer Research Center have achieved a significant scientific breakthrough in efforts to disable the Epstein-Barr virus. The Epstein-Barr virus, also known as ...
Neurology Advisor: “Should we characterize Epstein-Barr virus (EBV) as a causative agent of multiple sclerosis (MS), or a risk factor for MS?” Micah Luftig, PhD: “I think we should characterize EBV as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results